Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer
1st November 2024 • Oncology Today with Dr Neil Love • Dr. Neil Love
00:00:00
00:59:29